GLPG(GLPG)
GLPG
ANALYST COVERAGE23 analysts
HOLD
▲ +18.8%upside to target
PRICE
Prev Close
27.40
Open
27.13
Day Range27.09 – 27.89
27.09
27.89
52W Range24.74 – 37.78
24.74
37.78
23% of range
VOLUME & SIZE
Avg Volume
187.6K
FUNDAMENTALS
P/E Ratio
3.2x
Value territory
EPS (TTM)
—
Div Yield
No dividend
Beta
0.67
Low vol
TECHNICAL
RSI (14)
26
Oversold
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19
PDividend Pay
In 120 days
Sep 18
GLPG News
About
Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Paul Stoffels
Country
Belgium
Website
Henry GosebruchChief Executive Officer & Executive Director
Annelies MissottenExecutive Officer
Marieke VermeerschHead of Corporation Communication
Aaron L. CoxChief Financial Officer
Fred W. BlakesleeExecutive Vice President & General Counsel
Tania PhilippChief Human Resources Officer
Glenn SchulmanHead of Investor Relations
Jeevan ShettyHead of Clinical Development Oncology
Ellen Van Der AarHead of Development
Ruiz AstigarragaHead of Manufacturing Cell Therapy